A detailed history of Radnor Capital Management, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Radnor Capital Management, LLC holds 17,653 shares of BAX stock, worth $593,317. This represents 0.13% of its overall portfolio holdings.

Number of Shares
17,653
Previous 15,653 12.78%
Holding current value
$593,317
Previous $605,000 24.63%
% of portfolio
0.13%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$37.88 - $43.77 $75,760 - $87,540
2,000 Added 12.78%
17,653 $754,000
Q4 2023

Jan 11, 2024

SELL
$31.71 - $38.95 $152,366 - $187,154
-4,805 Reduced 23.49%
15,653 $605,000
Q3 2023

Oct 12, 2023

BUY
$37.32 - $49.29 $763,492 - $1.01 Million
20,458 New
20,458 $772,000
Q1 2023

Apr 06, 2023

BUY
$37.58 - $52.57 $48,854 - $68,341
1,300 Added 9.09%
15,605 $633,000
Q3 2022

Oct 12, 2022

SELL
$53.86 - $66.8 $21,544 - $26,720
-400 Reduced 2.72%
14,305 $770,000
Q2 2022

Jul 11, 2022

BUY
$63.83 - $80.0 $139,404 - $174,720
2,184 Added 17.44%
14,705 $945,000
Q1 2022

Apr 25, 2022

BUY
$76.85 - $89.45 $222,864 - $259,405
2,900 Added 30.14%
12,521 $971,000
Q4 2021

Jan 20, 2022

BUY
$74.57 - $87.19 $717,437 - $838,854
9,621 New
9,621 $826,000
Q3 2021

Oct 26, 2021

SELL
$73.77 - $83.61 $527,676 - $598,062
-7,153 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$78.33 - $90.73 $39,165 - $45,365
-500 Reduced 6.53%
7,153 $575,000
Q1 2020

Apr 07, 2020

BUY
$71.57 - $93.3 $14,313 - $18,660
200 Added 2.68%
7,653 $622,000
Q3 2019

Oct 07, 2019

SELL
$81.4 - $89.78 $8,140 - $8,978
-100 Reduced 1.32%
7,453 $652,000
Q2 2019

Jul 18, 2019

SELL
$73.44 - $82.41 $22,032 - $24,723
-300 Reduced 3.82%
7,553 $619,000
Q2 2017

Aug 09, 2017

BUY
N/A
7,853
7,853 $475,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.